PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 20, 2026American Journal of Respiratory and Critical Care Medicine0 citations

A80-3-41 The Nodule That Got to the Heart of the Matter: An Atypical Presentation of Cardiac Amyloidosis as a Pulmonary Nodule

View Full Paper
TAT T AdeboInova Health SystemRHR S HalabiInova Health SystemELE A LibreInova Health System

Key Result

Wild-type ATTR cardiac amyloidosis atypically presented as a 1.9 cm pulmonary nodule mimicking malignancy in a 79-year-old male, which was subsequently managed with Tafamidis.

Key Points

  • To discuss a rare case where cardiac amyloidosis presented as a pulmonary nodule rather than typical cardiac symptoms.
  • Case report of a 79-year-old male with atypical presentation of wild-type ATTR cardiac amyloidosis.
  • Diagnostic evaluations included echocardiogram, CT imaging, PET/CT, histopathology, and cardiac MRI.
  • Management involved starting Tafamidis after diagnosis confirmation.
  • Initial CT imaging revealed a 1.5 cm peripheral nodule, which later enlarged to 1.9 cm with new FDG avidity.
  • Histopathology confirmed necrotizing granulomatous inflammation and ATTR amyloidosis using Congo red staining.
  • Post-management, the patient's heart failure improved significantly, indicating effective treatment.

Study Design

Type

Case Report (n=1)

Structured PICO

P
Population
79-year-old male with a past medical history of coronary artery disease (status post 5-vessel bypass surgery and previous infarction), hypertension, hyperlipidemia, type 2 diabetes, and a prior smoking history presenting with a 6-month history of a nonproductive cough and dyspnea on exertion.
I
Intervention
Tafamidis

Cardiac amyloidosis can atypically present as a pulmonary nodule mimicking malignancy, highlighting the need for a broad differential diagnosis in elderly patients.

Abstract

Abstract Introduction Cardiac amyloidosis is a condition characterized by extracellular deposition of insoluble protein within the cardiac tissue. Transthyretin (ATTR) cardiac amyloidosis is an increasingly recognized but underdiagnosed cause of restrictive cardiomyopathy in older adults. Affected patients typically present with symptoms of heart failure or arrhythmias that are usually identified through cardiac imaging findings and cardiac biopsy. Atypical presentations of cardiac amyloidosis can delay diagnosis and treatment. This is a case of wild-type ATTR amyloidosis that initially presented mimicking a pulmonary malignancy in an elderly male. Case Presentation A 79-year-old male with a past medical history of coronary artery disease (status post 5-vessel bypass surgery and previous infarction), hypertension, hyperlipidemia, type 2 diabetes, and a prior smoking history who presented with a 6-month history of a nonproductive cough and dyspnea on exertion. His initial workup included an echocardiogram that showed an ejection fraction of 45%. CT imaging showed a 1.5 cm peripheral nodule that was non-FDG avid on PET/CT. He made clinical progress with management of his heart failure, and serial follow-up imaging showed stability of the nodule. However, two years from the initial evaluation, the nodule unexpectedly enlarged to 1.9 cm (Figure 1) with new FDG avidity on repeat PET/CT, raising concern for malignancy. The suspicious nodule was resected, with histopathology revealing necrotizing granulomatous inflammation with amyloid deposition confirmed by Congo red staining. Mass spectroscopy identified wild-type ATTR amyloidosis. Cardiac MRI demonstrated a non-ischemic cardiomyopathy with diffuse delayed enhancement and biventricular involvement. A technetium-99m pyrophosphate scan showed grade 3 myocardial uptake, confirming ATTR cardiac amyloidosis. He was started on Tafamidis and now, two years later, his heart failure has come under much better control. Discussion This case presents a rare instance in which a pulmonary nodule served as the initial manifestation of cardiac amyloidosis. It highlights that even nodules appearing suspicious for malignancy on PET imaging could, in fact, be due to amyloidosis. Despite the presence of cardiac symptoms at presentation, this case was unique in that the clinical features were not consistent with the typical manifestations of cardiac amyloidosis. Heart failure with preserved ejection fraction is the usual presentation of cardiac amyloidosis; this patient instead had heart failure with a reduced ejection fraction. His prior MI and CAD are potential contributors to this atypical picture. In summary, keeping a broad differential in mind is important, especially in elderly patients who present with suspicious lung nodules. This abstract is funded by: None

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Adebo et al. (2026) conducted a case report in Cardiac amyloidosis (n=1). Tafamidis was evaluated. Wild-type ATTR cardiac amyloidosis atypically presented as a 1.9 cm pulmonary nodule mimicking malignancy in a 79-year-old male, which was subsequently managed with Tafamidis.

synapsesocial.com/papers/6a0d4f34f03e14405aa9a7a3https://doi.org/10.1093/ajrccm/aamag162.3719
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 160 Uncommon Presentations of Cardiac Amyloidosis2025
  2. 2Wild-type transthyretin cardiac amyloidosis: a case of multisystemic involvement and review of literature2025
  3. 3A80-3-02 Nodular Pulmonary Amyloidosis Mimicking Lung Cancer2026
  4. 4Pulmonary involvement in transthyretin cardiac amyloidosis: a case report2024 · 1 citations
  5. 5C43-09 Cardio-Pulmonary Amyloidosis: A Rare Cause of Dyspnea2026